0001209191-21-007942.txt : 20210204
0001209191-21-007942.hdr.sgml : 20210204
20210204204252
ACCESSION NUMBER: 0001209191-21-007942
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210202
FILED AS OF DATE: 20210204
DATE AS OF CHANGE: 20210204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Labrucherie Gil M
CENTRAL INDEX KEY: 0001394875
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24006
FILM NUMBER: 21593000
MAIL ADDRESS:
STREET 1: 150 INDUSTRIAL ROAD
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS
CENTRAL INDEX KEY: 0000906709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943134940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4154825300
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC
DATE OF NAME CHANGE: 19980723
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS
DATE OF NAME CHANGE: 19940303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-02
0
0000906709
NEKTAR THERAPEUTICS
NKTR
0001394875
Labrucherie Gil M
C/O NEKTAR THERAPEUTICS
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94158
0
1
0
0
SVP, COO & CFO
Common Stock
2021-02-02
4
M
0
50000
8.80
A
316973
D
Common Stock
2021-02-02
4
S
0
41135
19.97
D
275838
D
Common Stock
2021-02-02
4
S
0
6932
20.96
D
268906
D
Common Stock
2021-02-02
4
S
0
1933
21.66
D
266973
D
Common Stock
2021-02-03
4
M
0
25000
8.80
A
291973
D
Common Stock
2021-02-03
4
M
0
25000
8.80
A
316973
D
Common Stock
2021-02-03
4
S
0
50000
19.61
D
266973
D
Common Stock
2021-02-04
4
M
0
50000
8.80
A
316973
D
Common Stock
2021-02-04
4
S
0
50000
19.81
D
266973
D
Stock Option
8.80
2021-02-02
4
M
0
50000
0.00
D
2017-02-06
2021-02-05
Common Stock
50000
25000
D
Stock Option
8.80
2021-02-03
4
M
0
25000
0.00
D
2017-02-06
2021-02-05
Common Stock
25000
0
D
Stock Option
8.80
2021-02-03
4
M
0
25000
0.00
D
2017-02-06
2021-02-05
Common Stock
25000
50000
D
Stock Option
8.80
2021-02-04
4
M
0
50000
0.00
D
2017-02-06
2021-02-05
Common Stock
50000
0
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021.
This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).
This transaction was executed in multiple trades at prices ranging from $19.55 to $20.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $20.56 to $21.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $21.57 to $21.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $19.30 to $19.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $19.50 to $20.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
Mark A. Wilson, Attorney-in-Fact
2021-02-04